Prostatic Neoplasms [clinicaltrials_resource:ee307364e412ffc5b8b1db8cc0636bce]
Familial Prostate Cancer [clinicaltrials:NCT00001377]A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [clinicaltrials:NCT00001382]Study of Prostate Cancer in Black and White U.S. Veterans [clinicaltrials:NCT00007540]Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer [clinicaltrials:NCT00031187]Ketoconazole Plus Docetaxel to Treat Prostate Cancer [clinicaltrials:NCT00032825]EPO906 Therapy in Patients With Prostate Cancer [clinicaltrials:NCT00035113]Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00036556]Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure [clinicaltrials:NCT00038662]Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer [clinicaltrials:NCT00039624]Massage Therapy for Cancer-Related Fatigue [clinicaltrials:NCT00039793]Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer [clinicaltrials:NCT00040170]clinicaltrials:NCT00040365Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 [clinicaltrials:NCT00040586]YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy [clinicaltrials:NCT00048659]Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies [clinicaltrials:NCT00050687]clinicaltrials:NCT00055471Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer [clinicaltrials:NCT00056654]clinicaltrials:NCT00060528Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma [clinicaltrials:NCT00061035]Phase I/II Dose Escalation Study of VELCADEĀ® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer [clinicaltrials:NCT00064610]MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer [clinicaltrials:NCT00070837]CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer [clinicaltrials:NCT00075192]Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors [clinicaltrials:NCT00080041]clinicaltrials:NCT00089609A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy [clinicaltrials:NCT00096551]Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 [clinicaltrials:NCT00106301]clinicaltrials:NCT00110526clinicaltrials:NCT00113984Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [clinicaltrials:NCT00120939]clinicaltrials:NCT00121095Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants [clinicaltrials:NCT00127465]clinicaltrials:NCT00137436Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy [clinicaltrials:NCT00152789]Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy [clinicaltrials:NCT00152919]Endorectal Coil Magnetic Resonance Images (ERC-MRI) [clinicaltrials:NCT00160953]Transrectal Tumour Oxygen - US Army [clinicaltrials:NCT00160979]Exisulind Versus Placebo After Surgical Removal of the Prostate [clinicaltrials:NCT00166426]Exisulind Prior to Radical Prostatectomy [clinicaltrials:NCT00166478]clinicaltrials:NCT00170157Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP [clinicaltrials:NCT00177125]
condition [clinicaltrials_vocabulary:condition]
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma [clinicaltrials:NCT00001266]Familial Prostate Cancer [clinicaltrials:NCT00001377]A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [clinicaltrials:NCT00001382]A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms [clinicaltrials:NCT00001444]A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00001446]Genetic Analysis of Hereditary Prostate Cancer [clinicaltrials:NCT00001469]Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002480]Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [clinicaltrials:NCT00002503]Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002511]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]clinicaltrials:NCT00002540clinicaltrials:NCT00002597clinicaltrials:NCT00002602clinicaltrials:NCT00002633Biological Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002637]clinicaltrials:NCT00002651Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer [clinicaltrials:NCT00002668]Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors [clinicaltrials:NCT00002677]Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer [clinicaltrials:NCT00002703]Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002721]clinicaltrials:NCT00002723clinicaltrials:NCT00002760Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002775]Group Therapy Compared With Educational Materials in Patients With Prostate Cancer [clinicaltrials:NCT00002848]clinicaltrials:NCT00002855clinicaltrials:NCT00002874Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002881]clinicaltrials:NCT00002889clinicaltrials:NCT00002924clinicaltrials:NCT00002938PET Scan in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002981]Hormone Therapy in Treating Patients With Advanced Prostate Cancer [clinicaltrials:NCT00003026]Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003038]Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer [clinicaltrials:NCT00003045]clinicaltrials:NCT00003084Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003104]Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy [clinicaltrials:NCT00003115]Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003124]Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer [clinicaltrials:NCT00003162]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma [clinicaltrials:NCT00001266]Familial Prostate Cancer [clinicaltrials:NCT00001377]A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [clinicaltrials:NCT00001382]A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms [clinicaltrials:NCT00001444]A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00001446]Genetic Analysis of Hereditary Prostate Cancer [clinicaltrials:NCT00001469]Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002480]Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [clinicaltrials:NCT00002503]Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002511]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]clinicaltrials:NCT00002540clinicaltrials:NCT00002597clinicaltrials:NCT00002602clinicaltrials:NCT00002633Biological Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002637]clinicaltrials:NCT00002651Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer [clinicaltrials:NCT00002668]Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors [clinicaltrials:NCT00002677]Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer [clinicaltrials:NCT00002703]Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002721]clinicaltrials:NCT00002723clinicaltrials:NCT00002760Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002775]Group Therapy Compared With Educational Materials in Patients With Prostate Cancer [clinicaltrials:NCT00002848]clinicaltrials:NCT00002855clinicaltrials:NCT00002874Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002881]clinicaltrials:NCT00002889clinicaltrials:NCT00002924clinicaltrials:NCT00002938PET Scan in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002981]Hormone Therapy in Treating Patients With Advanced Prostate Cancer [clinicaltrials:NCT00003026]Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003038]Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer [clinicaltrials:NCT00003045]clinicaltrials:NCT00003084Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003104]Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy [clinicaltrials:NCT00003115]Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003124]Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer [clinicaltrials:NCT00003162]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Prostatic Neoplasms [clinicaltrials_resource:ee307364e412ffc5b8b1db8cc0636bce]
Bio2RDF identifier
ee307364e412ffc5b8b1db8cc0636bce
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ee307364e412ffc5b8b1db8cc0636bce
identifier
clinicaltrials_resource:ee307364e412ffc5b8b1db8cc0636bce
title
Prostatic Neoplasms
@en
type
label
Prostatic Neoplasms [clinicaltrials_resource:ee307364e412ffc5b8b1db8cc0636bce]
@en
Prostatic Neoplasms